Genetic Testing for Psychiatric Medications

Dr. Pagnani: Medical Director and Founder of Rittenhouse Psychiatric Associates

Finding the right psychiatric medication often takes time, but genetic testing for psychiatric medications can help make treatment more personalized. Using pharmacogenomic testing, our psychiatrists evaluate how your genes influence the way your body metabolizes certain medications. Combined with your symptoms, medical history, and treatment goals, these insights help guide medication selection, reduce unnecessary trial and error, and support more informed prescribing decisions.

What Is Genetic Testing for Psychiatric Medications?

Genetic testing for psychiatric medications uses a simple cheek swab to analyze genetic variations that affect how your body processes antidepressants, anti-anxiety medications, mood stabilizers, ADHD medications, and other psychiatric treatments. The test primarily evaluates medication metabolism and may also provide insight into medication response and side effect risk, although research in these areas continues to evolve.

While many providers prescribe based on general guidelines, a psychiatrist using genetic testing can look at your unique metabolic profile. This data helps us make educated decisions about which medications your body can metabolize effectively and can also give insight regarding dosing strategies.

Who is Psychiatric Genetic Testing for?

While pharmacogenomic testing isn’t necessary for everyone, it may be especially helpful if you’ve experienced challenges finding an effective psychiatric medication or want additional information before beginning treatment.

• Treatment-resistant depression or anxiety: Multiple medication trials have not provided adequate symptom relief.
• Medication sensitivity: You frequently experience side effects or have difficulty tolerating psychiatric medications.
• Before starting treatment: You want additional insight into how your body may metabolize medications.
• Complex medication history: Previous medications have produced inconsistent results despite proper use.

What is Included in a Psychiatric Genetic Testing Report?

Your pharmacogenomic report summarizes how your genes may influence medication metabolism and prescribing decisions. Depending on the laboratory, reports typically include:

• Genes analyzed: Key genetic variants associated with psychiatric medication metabolism.
• Metabolizer status: Whether you are a poor, intermediate, normal, rapid, or ultrarapid metabolizer.
• Medication guidance: Categories identifying medications that may require dosage adjustments or closer monitoring.
• Clinical insights: Additional information about gene variants that may influence medication response, where supported by evidence.

Benefits and Limitations of Genetic Testing for Psychiatric Medications

Pharmacogenomic testing provides valuable information, but it is only one component of personalized psychiatric care. Medication decisions should always be made alongside a comprehensive clinical evaluation.

• Genetics are only one factor: Age, medical conditions, lifestyle, and symptoms also influence medication response.
• Liver and kidney function matter: Organ function plays a major role in how medications are processed.
• Drug interactions remain important: Testing cannot predict interactions between medications or supplements.
• Evidence continues to grow: While pharmacogenomics is supported for certain medications, it is not recommended for every psychiatric condition.
• Clinical expertise remains essential: Results are interpreted alongside your health history and treatment goals.

How Genetic Testing for Psychiatric Medications Can Improve Treatment

Pharmacogenomic testing can provide valuable insights when medications haven’t worked as expected. The following examples illustrate how genetic information may help guide treatment decisions.

1. The “Rapid Metabolizer” (CYP450 Enzyme)

• The Problem: A patient suffers from low mood and high anxiety. They are frustrated because they have tried standard medications like Prozac (Fluoxetine), Paxil (Paroxetine), and Effexor (Venlafaxine) with no success.
• The Genetic Insight: Testing reveals the patient is a “Rapid Metabolizer” at the P450-2D6 enzyme. This means their liver breaks down these specific medications too quickly for them to work.
• The Solution: Our psychiatrists transition the patient to Zoloft (Sertraline), which is metabolized by a different enzyme (CYP450-2C19).
• The Result: The depression and anxiety may resolve at a normal dose without significant side effects.

2. The MTHFR Gene Mutation

• The Problem: The MTHFR gene produces an enzyme necessary to utilize Vitamin B9 (Folic Acid). Up to half the population may have a mutation here, decreasing their ability to transform Folic Acid into L-Methylfolate (the active form required to create Serotonin, Norepinephrine, and Dopamine).
• The Genetic Insight: A test confirms an MTHFR heterozygous gene mutation.
• The Solution: Instead of adding a psychiatric medication, or increasing an already high doses, we may simply add the supplement L-Methylfolate to the patient’s regimen.
• The Result: Significant improvement in depression and anxiety by addressing the root biological deficiency, may be noted.

Our Process for Genetic Testing for Mental Health Medications

We make genetic testing for psychiatric medications simple and convenient for patients throughout Pennsylvania, New Jersey, Delaware, New York, Florida, and the surrounding areas.

• Consultation: Meet with one of our psychiatric providers to determine whether pharmacogenomic testing is appropriate.
• Sample Collection: Complete a painless cheek swab in our office or receive a home testing kit for telehealth appointments.
• Results Review: Once your results are available, we’ll explain what they mean and incorporate them into your personalized medication plan when appropriate.

Schedule an Appointment for Genetic Testing

At Rittenhouse Psychiatric Associates, we combine evidence-based psychiatry with personalized medicine to help patients make more informed treatment decisions. If you’re considering genetic testing for psychiatric medications, our team is here to determine whether pharmacogenomic testing is right for you.

Schedule your psychiatric evaluation today to learn whether pharmacogenomic testing could help personalize your medication plan and reduce unnecessary trial and error.

[Set Appointment]

FAQs About Psychiatric Genetic Testing

How accurate is genetic testing for psychiatric medications?

Your genetic testing results are based on your DNA, which remains the same throughout your lifetime, so the results generally do not need to be repeated. CLIA-certified laboratories use highly accurate testing methods to identify genetic variants related to medication metabolism. While the laboratory analysis is highly reliable, it’s important to understand that the test helps guide medication selection rather than predict with certainty which medication will work best. Your provider will interpret the results alongside your symptoms, medical history, and other clinical factors to create a personalized treatment plan.

Who can order genetic psychiatric testing, and how is the process conducted?

Testing must be ordered by a licensed medical provider (MD, DO, NP) during a consultation. The process is non-invasive and painless, requiring only a simple cheek swab done in our office or via a kit sent to your home.

Is there a genetic test for mental disorders?

No, genetic testing cannot diagnose conditions like Depression, Bipolar Disorder, or Anxiety; diagnosis requires a clinical evaluation. The test is strictly a tool to guide medication selection after a diagnosis has been made.

How much is genetic testing for psychiatric medications?

Costs for genetic testing vary by lab. Commercial insurance plans often cover the cost if you have a diagnosis of Major Depressive Disorder and have failed at least one medication. Patients would additionally pay the practice initial consultation fee, which is listed on our fees-and-policies page.